Trimetazidine May Potentially Confer Neuroprotective Effects against COVID-19-Induced Neurological Sequelae via Inhibition of Death-Associated Protein Kinase 1 (DAPK1) Signaling Pathways: An Evidenced-Based Hypothesis

Document Type : Letter to Editor

Authors

• Ali Aghajani ¹
• Zahra Khakpourian ¹
• Soodeh Bakhthiarzadeh ¹
• Fatemeh Adibipour ²
• Makan Sadr ³
• Natalie Coleman-Fuller ⁴
• Hamidreza Jamaati ¹
• Majid Motaghinejad ¹

¹ Chronic Respiratory Disease Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

² Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

³ Virology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran

⁴ Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN 55108.

Main Subjects

• Letter To Editor